 |
 |
 |
 |
 |
 |
 |
 |
E. William Radany, Ph.D., President and CEO
has over 25 years experience in the biotechnology industry. Prior to joining CODA, he was President and CEO of High Throughput Genomics, Inc., a provider of novel array-based gene expression assay technology for the life science industry. Dr. Radany was also previously President of Biacore, founder and CEO of NeoGenex and has held executive positions at Xencor, Caliper Technologies and Stratagene.
Alan Carter, Senior Vice President of Business Development and Marketing
has a broad range of pharmaceutical and research program strategic development through commercial management experiences with Biotrove, Gene Logic, Celera Genomics and Applied Biosystems.
Nancy Oleski, Ph.D., J.D., Senior Vice President of Intellectual Property and General Counsel
has been practicing law in the biotechnology industry for over seventeen years. Prior to joining CODA Genomics, she served as in-house consel at Amgen, Inc., Nuvelo, Inc., and Codexis, Inc.
Founders
G. Wesley (Wes) Hatfield, Ph.D.
is a CODA Founder and Professor Emeritus in the Schools of Medicine, Engineering, and Information and Computer Sciences at the University of California, Irvine. Wes also serves as Co-director of the UCI Institute for Genomics and Bioinformatics and as Director of the UCI Computational Biology Research Laboratory. The basic science that defines codon pair utilization patterns and their affects on protein translation were discovered in his UCI laboratory. Wes chairs the CODA scientific advisory board and is active in directing CODA research projects.
Richard (Rick) H. Lathrop, Ph.D.
is a CODA Founder and Professor in the School of Information and Computer Science at the University of California, Irvine. He holds a B.A. in Mathematics from Reed College, and a master's in Computer Science, the graduate degree of Electrical Engineer, and a Ph.D. in Artificial Intelligence from the Massachusetts Institute of Technology. Dr. Lathrop was also a co-founding scientist of Arris Pharmaceutical Corp. Rick was responsible for the computational designs which resulted in CODA’s self-assembling synthetic gene technology and continues to develop new computational solutions.